Core Laboratories Nv Stock Today
| CLB Stock | USD 12.12 0.03 0.25% |
PerformanceVery Weak
| Odds Of DistressVery Low
|
Core Laboratories is trading at 12.12 as of the 15th of April 2025, a 0.25 percent down since the beginning of the trading day. The stock's open price was 12.15. Core Laboratories has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 26th of April 2023 and ending today, the 15th of April 2025. Click here to learn more.
Business Domain Energy | IPO Date 20th of September 1995 |
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. The company has 46.7 M outstanding shares of which 6.61 M shares are currently shorted by investors with about 16.72 days to cover. More on Core Laboratories NV
Moving together with Core Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Core Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Lawrence Bruno | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Petroleum and Natural Gas (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [ATEX Resources Inc, Core Laboratories NV, Candy Club Holdings Ltd] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Oil & Gas Equipment & Services, Energy, NYSE Composite, SP Small-Cap 600, Petroleum and Natural Gas, Energy, Energy Equipment & Services, Oil & Gas Equipment & Services, Energy (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCore Laboratories can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Core Laboratories' financial leverage. It provides some insight into what part of Core Laboratories' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Core Laboratories NV (CLB) is traded on New York Stock Exchange in USA. It is located in 6316 Windfern Road, Houston, TX, United States, 77040 and employs 3,500 people. Core Laboratories is listed under Oil & Gas Equipment & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 568.83 M. Core Laboratories runs under Energy Equipment & Services sector within Energy industry. The entity has 46.7 M outstanding shares of which 6.61 M shares are currently shorted by investors with about 16.72 days to cover.
Core Laboratories NV has about 15.43 M in cash with 56.39 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Check Core Laboratories Probability Of Bankruptcy
Ownership AllocationThe majority of Core Laboratories NV outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Core Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Core Laboratories. Please pay attention to any change in the institutional holdings of Core Laboratories NV as this could imply that something significant has changed or is about to change at the company.
Check Core Ownership Details
Core Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 848 K | |
| Btim Corp | 2024-12-31 | 617.3 K | |
| Northern Trust Corp | 2024-12-31 | 577.8 K | |
| Fred Alger Management, Llc | 2024-12-31 | 556.5 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 499.3 K | |
| Bank Of New York Mellon Corp | 2024-12-31 | 450 K | |
| Van Eck Associates Corporation | 2024-12-31 | 443.6 K | |
| Gendell Jeffrey L | 2024-12-31 | 430.2 K | |
| Ubs Group Ag | 2024-12-31 | 377.1 K | |
| Ariel Investments, Llc | 2024-12-31 | 9.6 M | |
| Blackrock Inc | 2024-12-31 | 7.9 M |
Core Laboratories Historical Income Statement
Core Stock Against Markets
Core Laboratories Corporate Management
| Gwendolyn MBA | Senior Relations | Profile | |
| J Dumas | Vice President Business Development | Profile | |
| Martha Carnes | Presiding Non-Executive Lead Independent Member of the Supervisory Board | Profile | |
| Monique Eeuwijk | Non-Executive Independent Member of the Supervisory Board | Profile | |
| Jacobus Schouten | Managing Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.896 | Dividend Share 0.04 | Earnings Share 0.66 | Revenue Per Share | Quarterly Revenue Growth 0.008 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.